Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Lucid Diagnostics (LUCD) Equity Average (2022 - 2025)

Historic Equity Average for Lucid Diagnostics (LUCD) over the last 4 years, with Q3 2025 value amounting to $16.8 million.

  • Lucid Diagnostics' Equity Average rose 5099.25% to $16.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.8 million, marking a year-over-year increase of 5099.25%. This contributed to the annual value of $1.5 million for FY2024, which is 8514.66% down from last year.
  • Per Lucid Diagnostics' latest filing, its Equity Average stood at $16.8 million for Q3 2025, which was up 5099.25% from $1.2 million recorded in Q2 2025.
  • Over the past 5 years, Lucid Diagnostics' Equity Average peaked at $41.4 million during Q2 2022, and registered a low of $7000.0 during Q1 2025.
  • For the 4-year period, Lucid Diagnostics' Equity Average averaged around $14.7 million, with its median value being $12.5 million (2024).
  • Per our database at Business Quant, Lucid Diagnostics' Equity Average skyrocketed by 468734.69% in 2024 and then tumbled by 9985.39% in 2025.
  • Quarter analysis of 4 years shows Lucid Diagnostics' Equity Average stood at $25.3 million in 2022, then plummeted by 99.52% to $122500.0 in 2023, then surged by 4687.35% to $5.9 million in 2024, then surged by 187.3% to $16.8 million in 2025.
  • Its Equity Average stands at $16.8 million for Q3 2025, versus $1.2 million for Q2 2025 and $7000.0 for Q1 2025.